Intel Corp vs Tilray Brands Inc — how do they compare? Intel Corp trades at $106.23 (market cap $566.04B), while Tilray Brands Inc trades at $3.4 (market cap $530.54M). The key difference: Intel Corp is far larger — about 1066.9× Tilray Brands Inc's market cap, and Intel Corp pays a 2.24% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intel Corp for 116 Days and Tilray Brands Inc for 31 Days on average.
| INTC | TLRY | |
|---|---|---|
Market Cap | $566.04B | $530.54M |
Volume | 118,475,837 | 9,099,075 |
Sector | Technology | Health |
52-Week High | $140.94 | $21.00 |
52-Week Low | $33.62 | $3.57 |
Typical Hold Time | 116 Days | 31 Days |
Enterprise Value | $586.85B | $684.46M |
Dividend Yield | 2.24% | — |
Signals from Pluang's Aura AI — not financial advice
Intel (INTC) trades at $113.12, up 0.55% on the day, with a bullish technical signal supported by moving averages. Recent earnings beats and a 222% stock surge in 2026 reflect strong AI momentum and foundry growth, though negative net income and high valuation ratios signal caution. The company's cash flow improved in 2025, but competitive pressures and margin challenges persist.
The outlook hinges on Intel's foundry turnaround gaining traction, with revenue growth and external customer adoption as key catalysts. Risks include intense competition, high debt, and execution uncertainty. Analyst consensus is mixed, with a hold rating dominant, suggesting cautious optimism amid fundamental headwinds.
TLRY trades at $3.465, down 6.73% on the day and near 52-week lows, reflecting persistent bearish sentiment. The stock shows weak technical momentum with oversold RSI readings but faces fundamental challenges including consecutive quarterly earnings misses, negative profit margins, and declining revenue growth. Recent news highlights the company's struggles with profitability despite record annual revenue, with shares down over 50% year-to-date as investors question the cannabis company's path to sustainable growth.
TLRY presents a high-risk opportunity with significant downside protection from its low P/B ratio of 0.33, but requires substantial operational improvement to justify investment. The bullish case hinges on potential marijuana reform catalysts and BrewDog integration progress, while risks include ongoing losses, competitive pressures, and execution challenges in a volatile regulatory environment.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →